Molecular Profile | Unknown unknown |
Therapy | rigosertib |
Indication/Tumor Type | Advanced Solid Tumor |
Response Type | not applicable |
Create By | rliu |
Update By | smockus |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | Unknown unknown | Advanced Solid Tumor | not applicable | rigosertib | Phase I | Actionable | In a Phase I study, Estybon (rigosertib) demonstrated both saftey and efficacy in patients with advanced solid tumors (PMID: 23841031). | 23841031 |
---|
PubMed Id | Reference Title | Details |
---|---|---|
(23841031) | Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer. | Full reference... |